Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600513.SS

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 39.63 M

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Cash and Short-Term Investments is USD 39.63 M for the year ending December 31, 2023, a -17.28% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 47.91 M, a -7.94% change year over year.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 52.04 M, a 40.46% change year over year.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 37.05 M, a -10.56% change year over year.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 41.43 M, a -4.45% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Shanghai Stock Exchange: 600513.SS

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

CEO	Mr. Ben Niu
IPO Date	March 19, 2003
Location	China
Headquarters	No. 9 Jiankangyi Road
Employees	1,296
Sector	Consumers Staples
Industries Cleaning Supplies Chemicals & Advanced Materials Cosmetics Fertilizers Personal Care Petrochemicals Pharmaceuticals Plastics

Description

Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells chemical raw materials, preparations, and organic intermediates in China. The company offers cardiovascular, anti-allergic, urinary, anti-infective, and immunomodulatory products. The company was founded in 2000 and is headquartered in Yangzhou, China.

Key trends

Past 5 years